Quantitative Image Analysis of Cellular Heterogeneity in Breast Tumors Complements Genomic Profiling

Yinyin Yuan(University of Cambridge), Henrik Failmezger(Center for Integrated Protein Science Munich), Oscar M. Rueda(University of Cambridge), H. Raza Ali(University of Cambridge), Stefan Gräf(University of Cambridge), Suet‐Feung Chin(University of Cambridge), Roland F. Schwarz(University of Cambridge), Christina Curtis(University of Southern California), Mark Dunning(Cancer Research UK), Helen Bardwell(Cancer Research UK), Nicola Johnson(Cambridge University Hospitals NHS Foundation Trust), Sarah Doyle(Cambridge University Hospitals NHS Foundation Trust), Gulisa Turashvili(University of British Columbia), Elena Provenzano(Cambridge University Hospitals NHS Foundation Trust), Samuel Aparício(University of British Columbia), Carlos Caldas(University of Cambridge), Florian Markowetz(University of Cambridge)
Science Translational Medicine
October 24, 2012
Cited by 429

Abstract

Solid tumors are heterogeneous tissues composed of a mixture of cancer and normal cells, which complicates the interpretation of their molecular profiles. Furthermore, tissue architecture is generally not reflected in molecular assays, rendering this rich information underused. To address these challenges, we developed a computational approach based on standard hematoxylin and eosin-stained tissue sections and demonstrated its power in a discovery and validation cohort of 323 and 241 breast tumors, respectively. To deconvolute cellular heterogeneity and detect subtle genomic aberrations, we introduced an algorithm based on tumor cellularity to increase the comparability of copy number profiles between samples. We next devised a predictor for survival in estrogen receptor-negative breast cancer that integrated both image-based and gene expression analyses and significantly outperformed classifiers that use single data types, such as microarray expression signatures. Image processing also allowed us to describe and validate an independent prognostic factor based on quantitative analysis of spatial patterns between stromal cells, which are not detectable by molecular assays. Our quantitative, image-based method could benefit any large-scale cancer study by refining and complementing molecular assays of tumor samples.


Related Papers

No related papers found

Powered by citation graph analysis